Actively Recruiting
Dietary Intervention for NSCLC Patients Treated With ICI
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2024-08-12
80
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
CONDITIONS
Official Title
Dietary Intervention for NSCLC Patients Treated With ICI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed, informed consent
- Age 18 years or older
- Confirmed histological diagnosis of non-small cell lung cancer (NSCLC)
- Treatment with standard-of-care immune checkpoint inhibitor (ICI) therapy
- Ability to eat solid foods
You will not qualify if you...
- Severe dietary allergies (e.g., shellfish, nuts, seafood)
- Known psychiatric or substance abuse disorders interfering with trial cooperation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4
Actively Recruiting
Research Team
W
Wiam Belkaid, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here